The economic issue of vascular access within the Japanese medical reimbursement system.
The economic issue of vascular access within the Japanese medical reimbursement system.
J Vasc Access. 2015 Sep 5;0(0):0
Authors: Takemoto Y, Naganuma T
Abstract
We analyzed the current health economics of vascular access (VA) procedures in Japan. Results showed that the yearly VA-related medical expenses were as high as JPY20 billion and accounted for 1.4% of the total healthcare cost for chronic renal failure. The United States Renal Data System (USRDS) statistics showed that in the USA the yearly VA-related medical expenses accounted for 1.2% of the total medical cost for chronic renal failure, indicating that the costs did not differ much between the two countries. Moreover, percutaneous transluminal angioplasty (PTA) accounts for approximately 60% of VA procedures performed in Japan, and this ratio is increasing every year. Due to the aging of society and longer treatment periods, it is thought that PTA will become a significant procedure for the treatment of chronic renal failure in Japan.
PMID: 26349862 [PubMed - as supplied by publisher]
Source: The Journal of Vascular Access - Category: Surgery Tags: J Vasc Access Source Type: research
More News: Angioplasty | Economics | Health | Peripheral Angioplasty | Renal Failure | Statistics | Surgery